ArticleEBioMedicine2026
Microcephaly-like phenotype triggered by novel reassortant and prototypic Oropouche virus strains in brain organoids.
Article in EBioMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oropouche virus causes severe congenital disease in embryonic mice.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOropouche virus (OROV) is an emerging arbovirus currently spreading across South America, with increasing reports of neurological manifestations, severe systemic disease, and congenital abnormalities. Although traditionally associated with mild febrile illness, the recent geographic expansion and surge in OROV outbreaks have prompted attention to its neurotropic potential.
methodsWe investigated the effects of Oropouche virus (OROV) infection on neural stem cells (NSCs) and brain organoids derived from human induced pluripotent stem cells, using both an emergent reassortant isolate and a prototypical strain.
findingsOROV infected NSCs, leading to cell death, depletion of proliferative progenitors, and disruption of neuroepithelial organisation. Transcriptomic profiling revealed reduction of antiviral response genes and enrichment of signalling pathways related to viral replication, apoptosis, and inhibition of stem cell maintenance and neuronal differentiation. These molecular signatures aligned with phenotypic collapse of progenitor pools and cortical structure observed in organoids, in which OROV infected progenitors, neurons and astrocytes. Proteomic analysis of brain organoids infected with OROV showed regulation of neurodevelopment pathways, which have been previously associated with ZIKV infection, suggesting convergent pathway disruption associated with reduced growth of organoids infected by ZIKV and OROV and highlighting their potential to impair brain development.
interpretationThese results reveal evidence consistent with a previously unrecognised neurodevelopmental pathogenic potential of OROV strains and provide mechanistic insight into their contribution to microcephaly-like outcomes.
fundingD'Or Institute, ITpS, CNPq, FAPEMIG, FAPERJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.